Flu, cold, COVID or RSV: what the evidence says about telling them apart

Four different infections — influenza, the common cold, COVID-19, and respiratory syncytial virus (RSV) — produce broadly the same menu of symptoms: some combination of cough, congestion, sore throat, fever, headache, and fatigue. People try hard to read the differences off that menu, and the evidence says they cannot do it reliably. The overlap is not a gap in public knowledge; it is a real property of the diseases, because different viruses infecting the same airway tend to produce similar airway symptoms.

What symptom-spotting can and cannot do

The clearest data come from influenza, the one of the four with the sharpest classic presentation. A 2000 study in Archives of Internal Medicine examined which symptoms actually predicted a positive influenza test during flu season, and found that the combination of fever and cough was among the best simple predictors — but even then it was far from definitive, correctly flagging influenza only in a portion of cases and missing others [s1]. Two lessons come out of that. First, the abrupt onset of fever, aches and a dry cough does shift the odds toward flu rather than a cold, which tends to build gradually and stay in the nose and throat. Second, "shifts the odds" is as far as it goes: plenty of flu cases lack the textbook picture, and other viruses can mimic it. Crucially, that study was done in a season when influenza was known to be circulating [s1] — the same symptoms mean something different in a week when flu is everywhere than in one when it is not, which is why the background level of each virus, not the symptom list, often carries most of the diagnostic information.

RSV and COVID-19 muddy the picture further. RSV is best known as a serious illness in infants and older adults but causes ordinary cold-like illness in most healthy adults, and COVID-19's presentation has drifted toward upper-respiratory, cold-like symptoms as population immunity has grown. The practical consequence is that the only way to know which virus you have is to test for it — and the reason testing sometimes matters is not curiosity but that the treatments and the people at risk differ between them.

What actually helps: the prevention side is stronger than the cure side

Because there is no cure for any of these viral infections, the evidence on "what helps" splits into preventing spread and easing symptoms, and the prevention evidence is the more solid of the two. A 2023 Cochrane review of physical interventions found that measures such as hand hygiene probably modestly reduce the spread of respiratory viruses, while being candid that the trials are of variable quality and that the effects of some measures were uncertain [s3]. That is a deliberately hedged conclusion, and it is worth taking at its own weight: simple hygiene helps somewhat; it is not a force field.

On the symptom-easing side, the popular remedies fare less well than their reputations. The best-studied is vitamin C. A Cochrane review found that routine vitamin C supplementation did not reduce the incidence of colds in the general population (a pooled risk ratio of 0.97), though regular supplementation before any illness modestly shortened how long colds lasted — by about 8% in adults and 14% in children — and taking it only once symptoms started showed no consistent benefit [s2]. That is the shape of most cold-and-flu self-care evidence: small effects at best, often on duration rather than prevention, and frequently overstated in marketing.

Where the differences do matter

None of this means the four illnesses are interchangeable. They diverge most where it counts — in who gets seriously ill and in what can be done about it. Influenza and COVID-19 both have specific antiviral drugs and vaccines, and RSV now has vaccines for older adults and protection for infants, while the common cold has neither because it is caused by dozens of different viruses. Those differences are exactly why a test can change management for someone at higher risk, even though the symptoms look alike. For most healthy adults with a mild respiratory illness the label matters less than the trajectory, and anyone who is very unwell, breathless, or in a high-risk group needs clinical assessment rather than a symptom checklist. This explainer describes what the evidence shows about distinguishing these infections; it does not diagnose any particular illness.